126 related articles for article (PubMed ID: 31336144)
1. TLR3 preconditioning induces anti-inflammatory and anti-ictogenic effects in mice mediated by the IRF3/IFN-β axis.
Kostoula C; Shaker T; Cerovic M; Craparotta I; Marchini S; Butti E; Pascente R; Iori V; Garlanda C; Aronica E; Martino G; Ravizza T; Carmant L; Vezzani A
Brain Behav Immun; 2019 Oct; 81():598-607. PubMed ID: 31336144
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β.
Costello DA; Lynch MA
Hippocampus; 2013 Aug; 23(8):696-707. PubMed ID: 23554175
[TBL] [Abstract][Full Text] [Related]
3. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
5. Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents.
Pan LN; Zhu W; Li Y; Xu XL; Guo LJ; Lu Q; Wang J
PLoS One; 2014; 9(6):e99526. PubMed ID: 24914679
[TBL] [Abstract][Full Text] [Related]
6. The inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.
Hsieh MY; Chang MY; Chen YJ; Li YK; Chuang TH; Yu GY; Cheung CH; Chen HC; Maa MC; Leu TH
J Biol Chem; 2014 Mar; 289(13):9208-20. PubMed ID: 24526685
[TBL] [Abstract][Full Text] [Related]
7. Alteration of TLR3 pathways by glucocorticoids may be responsible for immunosusceptibility of human corneal epithelial cells to viral infections.
Hara Y; Shiraishi A; Kobayashi T; Kadota Y; Shirakata Y; Hashimoto K; Ohashi Y
Mol Vis; 2009 May; 15():937-48. PubMed ID: 19452017
[TBL] [Abstract][Full Text] [Related]
8. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
9. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
[TBL] [Abstract][Full Text] [Related]
11. Control of FoxO4 Activity and Cell Survival by TRIM22 Directs TLR3-Stimulated Cells Toward IFN Type I Gene Induction or Apoptosis.
Oteiza A; Mechti N
J Interferon Cytokine Res; 2015 Nov; 35(11):859-74. PubMed ID: 26237181
[TBL] [Abstract][Full Text] [Related]
12. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
13. Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells.
Palchetti S; Starace D; De Cesaris P; Filippini A; Ziparo E; Riccioli A
J Biol Chem; 2015 Feb; 290(9):5470-83. PubMed ID: 25568326
[TBL] [Abstract][Full Text] [Related]
14. Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cells.
Hirono K; Imaizumi T; Aizawa T; Watanabe S; Tsugawa K; Shiratori T; Kawaguchi S; Seya K; Matsumiya T; Ito E; Tanaka H
Mod Rheumatol; 2020 Nov; 30(6):1074-1081. PubMed ID: 31625434
[No Abstract] [Full Text] [Related]
15. LY294002 inhibits TLR3/4-mediated IFN-β production via inhibition of IRF3 activation with a PI3K-independent mechanism.
Zhao W; Qi J; Wang L; Zhang M; Wang P; Gao C
FEBS Lett; 2012 Mar; 586(6):705-10. PubMed ID: 22285490
[TBL] [Abstract][Full Text] [Related]
16. Effects of Toll-like receptor 3 on herpes simplex virus type-1-infected mouse neural stem cells.
Sun X; Shi L; Zhang H; Li R; Liang R; Liu Z
Can J Microbiol; 2015 Mar; 61(3):201-8. PubMed ID: 25633775
[TBL] [Abstract][Full Text] [Related]
17. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production.
Siednienko J; Gajanayake T; Fitzgerald KA; Moynagh P; Miggin SM
J Immunol; 2011 Feb; 186(4):2514-22. PubMed ID: 21248248
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin H deficiency decreases hypoxia-ischemia-induced hippocampal atrophy in neonatal mice through attenuated TLR3/IFN-β signaling.
Ni J; Zhao J; Zhang X; Reinheckel T; Turk V; Nakanishi H
J Neuroinflammation; 2021 Aug; 18(1):176. PubMed ID: 34376208
[TBL] [Abstract][Full Text] [Related]
19. NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.
Audry M; Ciancanelli M; Yang K; Cobat A; Chang HH; Sancho-Shimizu V; Lorenzo L; Niehues T; Reichenbach J; Li XX; Israel A; Abel L; Casanova JL; Zhang SY; Jouanguy E; Puel A
J Allergy Clin Immunol; 2011 Sep; 128(3):610-7.e1-4. PubMed ID: 21722947
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells.
Mori K; Fujisawa T; Kusagaya H; Yamanaka K; Hashimoto D; Enomoto N; Inui N; Nakamura Y; Maekawa M; Suda T
PLoS One; 2015; 10(9):e0139491. PubMed ID: 26418032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
